AVALO THERAPEUTICS INC shareholders Q3 2023

AVALO THERAPEUTICS INC's ticker is and the CUSIP is 05338F207. A total of 29 filers reported holding AVALO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

AVALO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Virtu Financial LLC 185,345$220.00%
Baader Bank Aktiengesellschaft 184,373$19,8230.00%
VANGUARD GROUP INC 91,817$11,0820.00%
First Horizon Advisors, Inc. 276$330.00%
JANE STREET GROUP, LLC 27,482$3,3170.00%
UBS Group AG 112$140.00%
OSAIC HOLDINGS, INC. 347$420.00%
FIFTH THIRD BANCORP 279$340.00%
Parallel Advisors, LLC 1$00.00%
WELLS FARGO & COMPANY/MN 1,241$1500.00%
NORTHERN TRUST CORP 10,836$1,3080.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 174$210.00%
GEODE CAPITAL MANAGEMENT, LLC 133,518$16,1150.00%
STATE STREET CORP 25,643$3,0950.00%
MEEDER ASSET MANAGEMENT INC 62$70.00%
MORGAN STANLEY 10,514$1,2690.00%
ACADIAN ASSET MANAGEMENT LLC 283,306$340.00%
BlackRock Inc. 104,690$12,6360.00%
Mariner, LLC 18,582$2,2430.00%

This page lists AVALO THERAPEUTICS INC's shareholders in Q3 2023. To view AVALO THERAPEUTICS INC's shareholder history, click here.